Stockreport

Adaptimmune Therapeutics PLC (ADAP) Q3 2024 Earnings Call Highlights: Strategic Restructuring ... [Yahoo! Finance]

Adaptimmune Therapeutics plc - American Depositary Shares  (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report
PDF Total Operating Expenditure: $55.6 million in Q3 2024. Operating Expense Reduction: Expected reduction of approximately 25% in 2025 and over 30% in subsequent years. [Read more]